Phencyclidine

From WikiMD's Wellness Encyclopedia

(Redirected from Sernyl)

Phencyclidine (fen sye' kli deen) is an arylcyclohexylamine anesthetic that acts as a noncompetitive inhibitor of N-methyl-d-aspartate (NMDA) receptors in the brain.

Phencyclidine structure

Other names[edit | edit source]

Phencyclidine (fen sye' kli deen), commonly known as PCP, is an arylcyclohexylamine anesthetic that acts as a noncompetitive inhibitor of N-methyl-d-aspartate (NMDA) receptors in the brain.

History[edit | edit source]

PCP was initially developed as a human anesthetic but was later withdrawn due to its adverse psychological and behavioral effects. This article will discuss the clinical use, side effects, and recreational abuse of phencyclidine, as well as the development of related anesthetic agents.

Clinical Use and Indications[edit | edit source]

Phencyclidine infusions rapidly produce anesthesia and a unique cataleptic state characterized by profound analgesia, unresponsiveness, and amnesia, often with maintenance of muscle tone, involuntary movements, open eyes, and spontaneous breathing. This effect is called dissociative anesthesia, which can be associated with vivid hallucinations, agitation, and delirium during emergence. Due to these disturbing psychological and behavioral effects, phencyclidine (Sernyl) was withdrawn from human use in 1965. The drug continued to be available as a veterinary anesthetic (Sernylan) but was withdrawn from that use in 1978 in attempts to control its illicit availability.

Side Effects[edit | edit source]

Phencyclidine's dissociative effects led to its recreational abuse in the late 1960s and 1970s when it became a major drug of abuse, commonly known as "angel dust." When taken by mouth or inhaled (smoked) in doses of 1 to 10 mg, PCP leads to rapid onset of euphoria and feelings of omnipotence, superhuman strength, and social and sexual prowess. Chronic use of phencyclidine can be associated with severe violent and aggressive behavior and episodes of acute psychosis. Higher doses cause progressive confusion, disorientation, coma, and seizures, potentially leading to malignant hyperthermia, shock, rhabdomyolysis, renal failure, and sudden death. In recent years, increased awareness of its dangerous effects and limitations on its production have led to a decrease in the frequency (but not disappearance) of PCP abuse.

Development of Related Anesthetic Agents[edit | edit source]

Attempts to modify the tertiary amine structure of phencyclidine to develop a safer and more useful anesthetic agent led to the development of ketamine, another anesthetic with a similar mechanism of action. Ketamine shares some of PCP's dissociative effects, although to a lesser extent, and has a similar potential for abuse.

References[edit | edit source]

  • Domino, E. F. (2010). Taming the Ketamine Tiger. Anesthesiology, 113(3), 678-684. doi:10.1097/ALN.0b013e3181ede0e7
  • Giannini, A. J. (2000). Phencyclidine: An Update. Journal of Psychoactive Drugs, 32(4), 455-458. doi:10.1080/02791072.2000.10400241
  • Jansen, K. L. (2001). A review of the nonmedical use of ketamine: Use, users and consequences. Journal of Psychoactive Drugs, 32(4), 419-433. doi:10.1080/02791072.2000.10400224
  • Morris, H., & Wallach, J. (2014). From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, 6(7-8), 614-632. doi:10.1002/dta.1620
  • Olney, J. W., & Farber, N. B. (1995). NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology, 13(4), 335-345. doi:10.1016/0893-133X(95)00093-R
  • White, P. F., & Trevor, A. J. (1989). Phencyclidine and ketamine: A view from the street. Anesthesiology, 71(5), 787-789. doi:10.1097/00000542-198911000-00023

Further Reading[edit | edit source]

  • Gahlinger, P. M. (2004). Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine. American Family Physician, 69(11), 2619-2626. Retrieved from https://www.aafp.org/afp/2004/0601/p2619.html
  • Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G. K., Delaney, R., Bremner, J. D., ... & Charney, D. S. (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry, 51(3), 199-214. doi:10.1001/archpsyc.1994.03950030035004
  • Luby, E. D., Cohen, B. D., Rosenbaum, G., Gottlieb, J. S., & Kelley, R. (1959). Study of a new schizophrenomimetic drug; sernyl. AMA Archives of Neurology & Psychiatry, 81(3), 363-369. doi:10.1001/archneurpsyc.1959.02340150095011
Phencyclidine Resources
Wikipedia


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD